Effect of Footwear on the Clinical, Functional, and Biomechanical Aspects in Elderly Women With Knee Osteoarthritis (OA)

• The clinical and functional aspects will be evaluated using a visual analogue scale (VAS) for pain, Western Ontario and McMaster Universities (WOMAC) and Lequesne questionnaires of quality of life in patients with knee osteoarthritis and testing of six-minute walk (6MWT).
• Biomechanical analysis of gait will be performed by infrared cameras and a force platform. From the data of kinematics and kinetics, will be calculated moments of the knee joint strength by inverse dynamics.

The process (steps) will be divided as follows:

• step 1, in this step there will be sorting and initial assessment of potential participants; pain will be evaluated through VAS, function and quality of life by means of questionnaires WOMAC and Lequesne and the 6MWT, and by evaluating the biomechanics of gait.
• step 2,(3 month follow-up), both groups will be evaluated again by the VAS and WOMAC and Lequesne questionnaires.
• step 3, after 6 months of starting the monitoring process, both groups will be reevaluated through the VAS, WOMAC, Lequesne, 6MWT and biomechanical analysis of gait. This step is the final evaluation, characterizing the end of intervention.

Inclusion criteria

• Kellgren and Lawrence grade 2 or 3
• Being able to walk independently for at least 6 hours per day without the aid of canes or attendant to perform their activities of daily living
• Knee pain between 3 and 8 on the visual analogue scale

Exclusion criteria

• Previous history of surgery on knees, ankles and hips in the last 2 years
• Neurological disease
• BMI > 35 kg/m2
• Difference in lower limb length > 1 cm
• Prostheses and / or lower limb orthoses
• Having received steroid injections and hyaluronic acid intra-articular knee in previous periods of three and six months respectively
• Present at the knee joint instability (positive test results in the medial collateral ligament, lateral, anterior and posterior drawer)
• OA of the hip and / or ankle incapacitating or diagnosed OA in lower limbs and spine
• Inflammatory arthritis (eg. rheumatoid arthritis)
• Asymptomatic OA of one or both knees
• Dementia or inability to provide consistent information
• Introduction of Nonsteroidal Anti-inflammatory Drugs and analgesic medications 8 weeks before inclusion or change of dosage of the same after the inclusion
• Being under physiotherapy or acupuncture treatment
• Patients with an indication of prosthesis or orthosis
• Patients who are already using a flexible and non-heeled shoes for more than 25 hours per week (3 ½ hours per day) over the past 6 months